Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the i-STAT TBI (traumatic brain injury) cartridge. The test runs on Abbott's portable i-STAT Alinity instrument, ...

Abbott Laboratories ABT recently received Health Canada approval for the i-STAT TBI test cartridge for use with whole blood. It is designed to help clinicians assess suspected concussion at the ...

Abbott Laboratories (NYSE:ABT) said that it has received FDA clearance for its i-STAT TBI test cartridge to be used with whole blood in the evaluation of patients with suspected concussions, allowing ...

East Windsor, New Jersey, October 2, 2007 — Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted waived status under the Clinical Laboratory Improvement Amendements of ...

Health Canada has granted approval for Abbott’s i-STAT TBI test cartridge, enabling clinicians to evaluate suspected concussions more effectively. The authorisation allows for the use of the test ...

The test can be used to evaluate patients up to 24 hours after injury. The Food and Drug Administration (FDA) has cleared the i-STAT ® TBI cartridge for use with whole blood to aid in the evaluation ...

Traumatic Brain Injury (TBI) happens to millions of people annually. It can strike anyone, from athletes to someone cooking lunch. Most of these injuries go undiagnosed, due to the invisible nature of ...

The test measures glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase L1, biomarkers present in blood plasma at elevated concentrations after a brain injury. The Food and Drug ...